Homocystinuria

60,363views

Homocystinuria

Foundations

Foundations

Introduction to the immune system
Innate immune system
Complement system
Contracting the immune response and peripheral tolerance
Cytokines
Monoclonal antibodies
Antibody classes
Bacterial structure and functions
B-cell development
B-cell activation, differentiation, and contraction
T-cell development
T-cell activation
B- and T-cell memory
MHC class I and MHC class II molecules
Thymus histology
Cell cycle
Mitosis and meiosis
DNA replication
DNA damage and repair
DNA mutations
Cell membrane
Free radicals and cellular injury
Hypoxia
Necrosis and apoptosis
Inflammation
Crohn disease
Gout
Gout and pseudogout: Pathology review
Inclusion body myopathy
Inflammatory bowel disease: Pathology review
Papulosquamous and inflammatory skin disorders: Pathology review
Myasthenia gravis
Systemic lupus erythematosus
Type I hypersensitivity
Type II hypersensitivity
Type III hypersensitivity
Type IV hypersensitivity
Serum sickness
Anaphylaxis
Graft-versus-host disease
Systemic lupus erythematosus (SLE): Pathology review
Pemphigus vulgaris
Stevens-Johnson syndrome
Rheumatic heart disease
Heart failure: Pathology review
Thrombosis syndromes (hypercoagulability): Pathology review
Body fluid compartments
Movement of water between body compartments
Hyponatremia
Pulmonary edema
Lymphedema
Coagulation (secondary hemostasis)
Platelet plug formation (primary hemostasis)
Erythropoietin
Hemophilia
Coagulation disorders: Pathology review
Platelet disorders: Pathology review
Blood components
Protein C deficiency
Protein S deficiency
Metaplasia and dysplasia
Multiple endocrine neoplasia: Pathology review
Oncogenes and tumor suppressor genes
Amyloidosis
Atrophy, aplasia, and hypoplasia
Environmental and chemical toxicities: Pathology review
Medication overdoses and toxicities: Pathology review
Multiple endocrine neoplasia
Substance misuse and addiction: Clinical
Toxidromes: Clinical
Deep vein thrombosis and pulmonary embolism: Pathology review
Heparin-induced thrombocytopenia
Myocardial infarction
Shock
Arterial disease
Atherosclerosis and arteriosclerosis: Pathology review
Carbohydrates and sugars
Childhood nutrition and obesity: Information for patients and families (The Primary School)
Fat-soluble vitamin deficiency and toxicity: Pathology review
Folate (Vitamin B9) deficiency
Iron deficiency anemia
Osteomalacia and rickets
Vitamin B12 deficiency
Water-soluble vitamin deficiency and toxicity: B1-B7: Pathology review
Wernicke-Korsakoff syndrome
Zinc deficiency and protein-energy malnutrition: Pathology review
Burns: Clinical
Burns
Hyperplasia and hypertrophy
Down syndrome (Trisomy 21)
Edwards syndrome (Trisomy 18)
Patau syndrome (Trisomy 13)
Klinefelter syndrome
Turner syndrome
Angelman syndrome
Prader-Willi syndrome
Fragile X syndrome
DiGeorge syndrome
Phenylketonuria (NORD)
Homocystinuria
Maple syrup urine disease
Disorders of fatty acid metabolism: Pathology review
Ornithine transcarbamylase deficiency
Post-transplant lymphoproliferative disorders (NORD)
Cytomegalovirus infection after transplant (NORD)
Epigenetics
Gene regulation
Independent assortment of genes and linkage
Inheritance patterns
Mendelian genetics and punnett squares
Evolution and natural selection
Antiphospholipid syndrome
Celiac disease
Graves disease
Multiple sclerosis
Diabetes mellitus
Chronic granulomatous disease
Immunodeficiencies: Clinical
Immunodeficiencies: Phagocyte and complement dysfunction: Pathology review
Immunodeficiencies: Combined T-cell and B-cell disorders: Pathology review
Immunodeficiencies: T-cell and B-cell disorders: Pathology review
Candida
Mycobacterium tuberculosis (Tuberculosis)
Tuberculosis: Pathology review
Pneumonia: Pathology review
Pneumonia
Salmonella (non-typhoidal)
Viral structure and functions
Hepatitis medications
Herpesvirus medications
Neuraminidase inhibitors
HIV (AIDS)
Nucleoside reverse transcriptase inhibitors (NRTIs)
Integrase and entry inhibitors
Non-nucleoside reverse transcriptase inhibitors (NNRTIs)
Protease inhibitors
Vaccinations: Clinical
The flu vaccine: Information for patients and families
Vaccinations

Flashcards

Homocystinuria

0 of 10 complete

Questions

USMLE® Step 1 style questions USMLE

0 of 1 complete

An 11-year-old girl is brought to the emergency room after sudden weakness in her right arm and leg and slurred speech. She has complained of intermittent chest pain during gym class and visual disturbances for the past 2 months. Her parent states that the patient’s performance in school has been poor recently. The family immigrated from Singapore 2 years ago. Her birth and development were unremarkable. Weight at the 50th percentile for her age, while height is at the 85th percentile. Temperature is 37.0°C (98.6°F), pulse is 94/min, respirations are 18/min, and blood pressure is 105/65 mmHg. Physical examination reveals kyphosis and pectus excavatum. Ophthalmic examination reveals bilateral lens luxations. Neurological examination reveals 2/5 power in her right upper and lower limb and positive Babinski sign on the right side. An inborn error of metabolism is suspected as the cause of this patient’s symptoms. Which of the following enzymes is most likely deficient in this patient? 

Transcript

Watch video only

In homocystinuria, “homocysteine” is a metabolite of the amino acid methionine, and “uria” means, a substance present in urine.

So people with homocystinuria have large amounts of homocysteine in their urine, as well as other problems in the connective tissue, muscles, brain, heart, and blood vessels.

Now, amino acids are the basic building blocks that make up proteins.

There are 20 amino acids used in the human body and they all contain a carboxyl (-COOH) group and an amine (-NH2) group.

Methionine is one of the essential amino acids, meaning our bodies can't create it, but they must be acquired through food that’s rich in protein like meat, eggs, dairy, avocados, beans, etc.

So the proteins you eat are broken down into amino acids in the gastrointestinal tract by gastric acid and digestive enzymes.

The amino acids are then absorbed by the small intestine into the bloodstream, and then travel to the cells of the body, where they are used for protein synthesis.

Since the body can’t store these amino acids, any excess amino acids are converted into glucose or ketones and used for energy.

Now methionine is also used to synthesize another amino acid, cysteine.

First, methionine is converted into the amino acid homocysteine through multiple steps.

Next, the enzyme cystathionine beta- synthase, which requires vitamin B6 as a substrate, combines homocysteine and serine to create cystathionine.

Finally, the enzyme cystathionase converts cystathionine into cysteine.

Any homocysteine that does not undergo this process can be converted back into methionine by methionine synthase, which requires vitamin B12, or cobalamin, and folate as substrates.

There are two types of homocystinuria: familial and acquired.

Familial homocystinuria is an autosomal recessive genetic disorder that first manifests early in life.

It’s usually caused by cystathionine beta-synthase deficiency, but it can also be caused by decreased B12 affinity in cystathionine beta- synthase, or methionine synthase deficiency.

Now, when there’s a problem with cystathionine beta- synthase, homocysteine cannot be combined with serine, so less cysteine is produced, and homocysteine builds up in the body.

If methionine synthase is defective, homocysteine can be converted into cysteine, but it can’t be converted back into methionine, which also leads to its accumulation.

Acquired homocystinuria happens later in life and is often caused by poor diet, where there are deficiencies in vitamin B6, B12, or folate.

B12 and folate deficiency decreases the activity of methionine synthase, while B6 deficiency does the same to cystathionine beta-synthase, both leading to the build up of homocysteine in the body.

Whatever the cause, when homocysteine builds up in the body, some of it is excreted in the urine leading to homocystinuria.

They also build up in the blood, where they bind to the endothelial cells lining blood vessels, causing them to secrete molecules called proinflammatory cytokines.

These attract immune cells like leukocytes to the area and cause inflammation, which leads to atherosclerosis, or plaque build up inside the arteries.

This narrows the arteries and could lead to ischemia of the tissue supplied by these arteries.

Furthermore, homocysteine also binds to platelets and cause them to stick to one another to make blood clots.

In the bones, homocysteine binds to fibrillin-1 proteins that normally provide structural support.